Dr Ingo Ringshausen - Department of Haematology
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo RINGSHAUSEN | University of Cambridge, Cambridge | Cam | Stem Cell Institute | Research profile
Dr Ingo Ringshausen - Department of Haematology
Frontiers | ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies
Dr Ingo Ringshausen | Wellcome-MRC Cambridge Stem Cell Institute
Ingo RINGSHAUSEN | University of Cambridge, Cambridge | Cam | Stem Cell Institute | Research profile
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen – The Conversation
Stroma Biosciences selected for Accelerate@Babraham Start-up Programme - Department of Haematology
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Spinout company Stroma Biosciences selected to take place in Accelerate@Babraham Start-up Programme | Wellcome-MRC Cambridge Stem Cell Institute
Ingo Ringshausen (@i_ringshausen) / Twitter
Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)
The way to improve survival rates among cancer patients could be through targetting normal cells
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo RINGSHAUSEN | University of Cambridge, Cambridge | Cam | Stem Cell Institute | Research profile
Ingo Ringshausen on Twitter: "Congrats indeed!" / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
NOTCH1 drives immune-escape mechanisms in B cell malignancies | bioRxiv
Ingo Ringshausen on Twitter: "Excellent talk indeed!" / Twitter
